Kiniksa Pharmaceuticals International (KNSA) EV to FCF (2022 - 2026)
Kiniksa Pharmaceuticals International's (KNSA) EV to FCF came in at 51.69 for Q2 2026, down 9.3% from 57.02 a year earlier but up 22.5% from the prior quarter.
Powered by 
Analysis
Kiniksa Pharmaceuticals International (KNSA) EV to FCF (2022 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EV to FCF at Kiniksa Pharmaceuticals International was 47.67, down 16.4% year-over-year; for FY2025, it was 43.18, down 58.3% from FY2024.
- Annual EV to FCF has declined for three consecutive years.
- In prior years, Kiniksa Pharmaceuticals International's EV to FCF was 103.50 in FY2024 (-39.9%), 172.20 in FY2023 (-48.3%) and 332.93 in FY2022.
- Quarterly EV to FCF has run from a low of 34.30 in Q1 2023 to a high of 326.35 in Q4 2022 over five years.
- On a year-over-year basis, EV to FCF has declined in each of the last seven quarters, with an average decline of 42.7% over the last seven quarters.
- The strongest year-over-year quarter for EV to FCF in the past five years was Q1 2024, with growth of 240.7%; the weakest was Q3 2025, with a decline of 82.1%.
- According to Business Quant data, EV to FCF for the three prior quarters was 42.19 (Q1 2026), 43.18 (Q4 2025) and 54.40 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Kiniksa Pharmaceuticals International | 11.64 Bn | 10.38 Bn | 220.03 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 51.69 |
| Mar 31, 2026 | 42.19 |
| Dec 31, 2025 | 43.18 |
| Sep 30, 2025 | 54.40 |
| Jun 30, 2025 | 57.02 |
| Mar 31, 2025 | 67.89 |
| Dec 31, 2024 | 103.50 |
| Sep 30, 2024 | 304.73 |
| Jun 30, 2024 | 80.45 |
| Mar 31, 2024 | 116.85 |
| Dec 31, 2023 | 172.20 |
| Jun 30, 2023 | 42.22 |
| Mar 31, 2023 | 34.30 |
| Dec 31, 2022 | 326.35 |
API Access
Kiniksa Pharmaceuticals International EV to FCF API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-fcf&ticker=KNSA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-fcf", "ticker": "KNSA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-fcf&ticker=KNSA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();